Sequential/Combination Therapy in Nucleoside or Nucleotide Analogue (NA)-Suppressed Chronic Hepatitis B Patients

NCT03332329 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: Entecavir
DRUG: Granulocyte Macrophage Colony Stimulating Factor
DRUG: Y peginterferon alfa-2b
DRUG: HBV vaccine

Sponsor

Qin Ning